鬆井股份(688157.SH):湖南三迪擬進行增資擴股引入戰略投資者
格隆匯6月20日丨鬆井股份(688157.SH)公佈,公司的控股子公司湖南三迪數字塗裝系統有限公司(以下簡稱“湖南三迪”)擬進行增資擴股引入戰略投資者,湖南湘江鬆井新材料產業投資合夥企業(有限合夥)(以下簡稱“新材料產業基金”)作爲投資方擬對湖南三迪投資人民幣2,867.2500萬元,其中647.0589萬元用於新增註冊資本,餘下2,220.1911萬元計入資本公積,取得增資後湖南三迪20.0000%的股權。公司及其他現有股東放棄對湖南三迪本次增資的優先認購權。
本次交易完成後,公司對湖南三迪的持股比例由77.2727%變更爲61.8182%,湖南三迪仍爲公司控股子公司,不影響公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.